Beryl Drugs Limited (BOM:524606)

Market Cap	112.03M
Revenue (ttm)	211.46M
Net Income (ttm)	5.79M
Shares Out	5.07M
EPS (ttm)	1.14
PE Ratio	19.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	844
Average Volume	3,496
Open	22.54
Previous Close	22.99
Day's Range	22.54 - 22.54
52-Week Range	17.35 - 46.00
Beta	0.15
RSI	61.69
Earnings Date	Aug 8, 2025

About Beryl Drugs

Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services. The company also exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In 2024, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.68%.